Novo Nordisk NVO
First Signal's file · in 1 issue · All companies
Wegovy and Ozempic
Every time it made the issue
We cover a company only when it moves enough to matter. Each row is one of those days, what we made of it, and how the stock did over the next 5 and 20 trading days, next to the S&P 500.
| Date | Where | Move | Our read | 5 days later | 20 days later |
|---|---|---|---|---|---|
| Wed, Nov 4, 2026 | Earnings | +5.0% | Beat earnings expectations and raised its 2026 outlook, citing GLP-1 sales, CNBC reported. | to come | to come |
Its biggest days of the past ten years
| Best days | Move |
|---|---|
| Tue, Aug 8, 2023 | +17.2% |
| Fri, Feb 6, 2026 | +9.9% |
| Fri, Jan 16, 2026 | +9.1% |
| Worst days | Move |
|---|---|
| Tue, Jul 29, 2025 | −21.8% |
| Fri, Dec 20, 2024 | −17.8% |
| Mon, Feb 23, 2026 | −16.4% |
Its reports
It doesn't file U.S. quarterly results reports, so there's no earnings record here. Next report: not yet announced.
Moves are daily closing prices. Past moves don't predict future ones.
